For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

The winter storm has brought heavy snow and ice to the region, impacting operations at Rick Husband Amarillo International ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

MANILA, NATIONAL CAPITAL REGION, PHILIPPINES, January 10, 2025 /EINPresswire / -- R3 Stem Cell recently opened a new location in Manila metro Philippines. The regenerative medicine clinic is in BGC ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic obstructive pulmonary disease (COPD).

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

The Thistle drug consumption room - the first of its kind in the UK - will open in Glasgow on Monday in a bid to drive down ...

Amid rising concern around respiratory illnesses in India, several state governments have raised surveillances and issued ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...